Bottleneck problems and solutions of clinical viral serological detection

陈瑜

DOI: https://doi.org/10.3760/cma.j.cn112866-20221012-00208

2022-01-01

Abstract:Clinical viral serological testing plays an important role in the diagnosis and treatment of viral infectious diseases such as pathogen screening, disease course monitoring and therapeutic effect evaluation. In recent years, the sensitivity and accuracy of viral serological detection have been greatly improved due to the development of new immunological techniques. However, compared with molecular detection technologies and other methods, there are still some bottleneck problems, such as insufficient sensitivity and specificity, lagging development of virus mutation detection methods, rapid detection diversity and lack of multiple detection methods. In the future, the development and application of emerging technologies such as magnetic nanoparticles and molecularly imprinted polymers, as well as the exploration of new technologies and methods combined with artificial intelligence, are expected to further improve the sensitivity and specificity, improve the detection speed and flux, and breaking through the existing bottleneck.